Patent assignee · CA · COMPANY

Zymeworks BC Inc.

15Patents
15Active
15Granted
54Portfolio score

Filing activity: Jun 29, 2018 → Jun 18, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US12076400B2 Methods of using a bispecific antigen-binding construct targeting HER2 in combination with CDK4/6 inhibitors for the treatment of breast cancer Chemistry; Metallurgy 0 Active
US11965036B2 Bispecific antigen-binding constructs targeting HER2 Chemistry; Metallurgy 0 Active
US12286489B2 Modified antigen binding polypeptide constructs and uses thereof Chemistry; Metallurgy 0 Active
US12060436B2 Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Chemistry; Metallurgy 0 Active
US11965019B2 Stabilized chimeric Fabs Chemistry; Metallurgy 0 Active
US12152083B2 Cytotoxic and anti-mitotic compounds, and methods of using the same Electricity 0 Active
US11617777B2 Cytotoxic and anti-mitotic compounds, and methods of using the same Emerging Cross-Sectional Technologies 0 Active
US12304954B2 Multivalent and bispecific antibody constructs and methods of use thereof Chemistry; Metallurgy 0 Active
US12304945B2 Engineered immunoglobulin heavy chain-light chain pairs and uses thereof Chemistry; Metallurgy 0 Active
US12303544B2 Cytotoxic and anti-mitotic compounds, and methods of using the same Emerging Cross-Sectional Technologies 0 Active
US12215166B2 Bispecific antigen binding constructs targeting HER2 Chemistry; Metallurgy 0 Active
US12157775B2 Methods of using bispecific antigen-binding constructs targeting HER2 Chemistry; Metallurgy 0 Active
US12357701B2 Anti-HER2 biparatopic antibody-drug conjugates and methods of use Chemistry; Metallurgy 0 Active
US12227591B2 Antigen-binding constructs targeting HER2 Physics 0 Active
US11591405B2 Cytotoxic and anti-mitotic compounds, and methods of using the same Electricity 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.